✦ LIBER ✦

Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidines

✍ Scribed by Gloria A. Breault; Rebecca P.A. Ellston; Stephen Green; S.Russell James; Philip J. Jewsbury; Catherine J. Midgley; Richard A. Pauptit; Claire A. Minshull; Julie A. Tucker; J.Elizabeth Pease

Book ID: 108477464
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 350 KB
Volume: 13
Category: Article
ISSN: 0960-894X
DOI: 10.1016/s0960-894x(03)00203-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design, Synthesis, and Evaluation of 2-M

Design, Synthesis, and Evaluation of 2-Methyl- and 2-Amino- N -aryl-4,5-dihydrothiazolo[4,5- h ]quinazolin-8-amines as Ring-Constrained 2-Anilino-4-(thiazol-5-yl)pyrimidine Cyclin-Dependent Kinase Inhibitors

✍ McIntyre, Neil A.; McInnes, Campbell; Griffiths, Gary; Barnett, Anna L.; Kontopi 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 1003 KB

The Identification of 2-(1 H -Indazol-4-

The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer †

✍ Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Ste 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 659 KB

Design, synthesis and bioevaluation of d

Design, synthesis and bioevaluation of dihydropyrazolo[3,4-b]pyridine and benzo[4,5]imidazo[1,2-a]pyrimidine compounds as dual KSP and Aurora-A kinase inhibitors for anti-cancer agents

✍ Rong-geng Fu; Qi-dong You; Lei Yang; Wu-tong Wu; Cheng Jiang; Xiao-li Xu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Correction to Discovery of a Novel Class

Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1 H -[1,2,3]triazolo[4,5- b ]pyrazin-6-yl)-1 H -pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer

✍ Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dubé, Michelle; Pairish, M 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 124 KB